3rd Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to the implementation of the Affordable Health Care Act; S. 3187, Food and Drug Administration Safety and Innovation Act, Title VIII, Generating Antibiotic Incentives Now; Issues related to drug safety and drug shortages.

Foreign entity interest: Astellas Phara, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
KEVIN MICHAEL KAPPEL —
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.